The extensive body of research on cholesterol’s role in leukemia, including 1,220 publications from 1980 to 2024, highlights its critical involvement in tumor cell survival, proliferation, and treatment resistance, with particular focus on areas like STAT3 signaling and multidrug resistance. Here, STAT3 is linked to leukemia.